Clinical trial
A Multiple Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of K0706 in Plasma and Cerebrospinal Fluid in Healthy Volunteers
NCT03445338 is registered in ClinicalTrials.gov with Sun Pharma Advanced Research Company Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multiple Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of K0706 in Plasma and Cerebrospinal Fluid in Healthy Volunteers
- Lead sponsor
- Sun Pharma Advanced Research Company Limited
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- April 15, 2018
- Completion date
- December 6, 2019
- Enrollment
- 18 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy